APCINTEX LIMITED
Company number 09088717 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£23,587,385
Balance sheet as at 2020-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2014-06-16
- Employees
- 2 (2020 accounts)
- Registered office
- Lilly House Basingview, Basingstoke, Hampshire, United Kingdom, RG21 4FA
- Postcode
- RG21 4FA
- Capital
- 283 GBP
- Accounts category
- Small
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-02-07
- Next due by
- 2027-02-21
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 8 current · 9 resigned
Group structure
Controlled by CENTESSA PHARMACEUTICALS (UK) LIMITED — since 2022-12-20
From persons-with-significant-control filings on the public register.
Data protection registration
Registered with the ICO as a data protection fee payer — ZA538129 (Tier 1), registered since 2019.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- apcintex.com
Previous company names
| Name | Date changed |
|---|---|
| SERPIN HAEMOSTATICS LIMITED | 2016-04-02 |
Previous registered addresses 3
| Address | Changed on |
|---|---|
| C/O THE CAMBRIDGE PARTNERSHIP LIMITED THE DOROTHY HODGKIN BUILDING, BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3AT, UNITED KINGDOM | 2020-09-08 |
| C/O C/O MEDICXI, 25 GREAT PULTENEY STREET, LONDON, W1F 9LT, ENGLAND | 2020-08-27 |
| C/O INDEX VENTURE MANAGEMENT LLP 3 BURLINGTON GARDENS, MAYFAIR, LONDON, W1S 3EP | 2016-09-15 |
Among its peers
Top 5%
by shareholders' funds, of 33 similar companies in RG
Trading since 2014.
No.1 of the largest research and experimental development on biotechnology companies in Reading →
Competitors Reading
This company ranks 1 among research and experimental development on biotechnology in Reading.
The class of 2014
38%
of the 357 companies in this sector incorporated in 2014 are still active today; 59% have since been dissolved.
A fact about the year, not a forecast for this company.